Cannabis stocks news - daily news on stocks on CSE, TSX, TSXV, OTC, NASDAQ and NYSE from InvestorIdeas.com
Friday 27 August 2021
Investor Ideas #Potcasts 600: #Cannabis News and #Stocks on the Move; (CSE: $BRAX.C) (OTC: $BRAXF) (OTC: $ERBB) (OTCQX: $AVCNF) (NASDAQ: $GNLN)
Investor Ideas #Potcasts
600: #Cannabis News and #Stocks on the Move; (CSE: $BRAX.C) (OTC: $BRAXF) (OTC:
$ERBB) (OTCQX: $AVCNF) (NASDAQ: $GNLN)
Delta, Kelowna, BC, August 27, 2021 (Invstoride, s.com Newswire) www.Investoride, as.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/082721-StocksToWatch.mp3
Read this in full at https://www.investorideas.com/news/2021/cannabis-potcasts/08271BRAX-ERBB-AVCNF-GNLN.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public and private company announcements.
Greenlane Holdings, Inc. (NASDAQ: GNLN), a global house of brands and
one of the largest sellers of premium cannabis accessories, child-resistant
packaging, and specialty vaporization products, announced that its stockholders have approved
the proposed merger with KushCo
Holdings, Inc., a premier provider of ancillary products and services to
the legal cannabis and CBD industries.
Over 99%
of the votes cast on the merger proposal were voted in favor of the
Transaction. Furthermore, each other proposal submitted to stockholders at
Greenlane’s annual meeting of stockholders was approved by the requisite vote.
The Company expects to file with the Securities and Exchange Commission a Form
8-K disclosing the final voting results.
Pursuant
to the terms of the merger agreement, KushCo will become a wholly owned
subsidiary of Greenlane in an all-stock, tax-free business combination. Under
the terms of the merger agreement, KushCo’s stockholders will receive shares of
Greenlane Class A common stock based on the final exchange ratio to be
determined as of the closing date in accordance with the terms of the merger
agreement.
Avicanna Inc. (OTCQX: AVCNF), a biopharmaceutical company
focused on the development, manufacturing and commercialization of
plant-derived cannabinoid-based products, announced that, through its majority-owned
Colombian subsidiary Santa Marta Golden Hemp S.A.S. (“SMGH”), it has completed
its first commercial export of 20 kg of high CBD full spectrum psychoactive
cannabis extracts (the “Cannabis Extracts”) to Brazil in connection with the
previously announced three (3) year master supply agreement that SMGH executed
with a leading Brazilian pharmaceutical in July, 2021.
This marks the 11th country to which
Avicanna has successfully completed export of Aureus-branded products in what
stands as a demonstration of the Company’s capabilities, innovation, and
regulatory expertise. This export also validates the emergence of the global
cannabinoid sector with reliance on quality, traceability and sustainability
that Avicanna’s Aureus products offer.
With a forecasted total market size
of approximately USD $9 billion by 2021, Brazil is expected to be one of the
biggest cannabis markets globally and the largest in Latin America,
particularly for medicinal cannabis products. The Cannabis Extracts will be
used in the production of several products which will be registered and
commercialized in Brazil through RDC 327/19 that regulates manufacturing,
registration, importation and dispensing of cannabis-derived products.
Lucas Nosiglia, President of
Avicanna LATAM, commented: “This export represents a key milestone for our team
and a validation of our capabilities as we continue to lead the way with our
products and have now entered our 11th country with the Aureus brand. The
export to Brazil also confirms the regulatory pathway and acts as a proof of
concept in the largest market in South America where we aim to establish
long-lasting supply relationships with our Brazilian pharmaceutical partners.”
American
Green
(OTC: ERBB) announced that it will be expanding its
E-commerce presence by launching on Groupon.com. American Green’s premium CBD and Hemp
products will be able to be purchased with vouchers located on the Groupon.com
platform beginning next month (September 2021).
The company is excited to add sales from Groupon as another revenue
stream and hopes to echo or exceed the success it is currently enjoying
following its launch on Amazon.com.
David G. Gwyther, American
Green’s president, said, “We are
extremely excited to offer our CBD products on Groupon.com There are very few e-commerce outlets that
sell CBD direct to consumers, and Groupon is by far the largest and most
successful platform. Groupon has over 24
million customers nationwide. Consumers
throughout the country will now have direct access to all of our CBD and Hemp
products on Groupon.com.”
“American Green is always looking
for innovative ways to introduce its CBD and Hemp products to new prospects and
new marketplaces. Groupon is perfectly aligned with our goals with respect to
pioneering new ideas that drive rapid growth in e-commerce environments,” said
Kevin Davis, VP President of Sales for American Green.
The American Green offers will be
optimized and marketed under Groupon's proprietary methods which include but
are not limited to: flash sale offers, remarketing campaigns, utilization of
additional channels (such as the Groupon app and partner websites) and other
online advertising channels.
Braxia
Scientific Corp. (CSE: BRAX) (OTC: BRAXF), a medical research company with
clinics providing innovative ketamine treatments for persons with depression
and related disorders, announced that Braxia Scientific's clinical
research and development team will commence a randomized clinical trial (RCT)
using psilocybin.
"This will be the broadest
study of its kind," said Dr. Joshua Rosenblat, the trial's principal
investigator and medical director of the Canadian Rapid Treatment Centre of
Excellence Inc. (CRTCE), a wholly owned subsidiary of Braxia Scientific.
"Whereas most other
treatment-resistant depression (TRD) studies limit participation to patients
that have not found relief from a maximum of five other potential remedies, our
research will not have an upper limit, and will even include patients that have
endured dozens of unsuccessful medical trials, including ketamine and
electroconvulsive therapy.
"By including everyone with
more than two failed medical trials, we are increasing the degree to which the
results can be applied to a larger population, making our findings much
stronger. Furthermore, we will have less exclusion criteria and are even
including patients with bipolar depression – a huge first for the field – or
comorbid disorders, which were excluded in psilocybin studies done by other
companies."
Braxia Scientific CEO Dr. Roger
McIntyre added, "Integrating psilocybin provides immense opportunity for
benefit for those dealing with treatment-resistant depression. Unfortunately,
over one-third of the more than 300 million people suffering with depression
worldwide fail to adequately respond to currently approved treatments, and thus
the TRD market is very large and disproportionately dominates the majority of
mental health services."
The study will demonstrate that the
Company can effectively conduct a randomized controlled trial using
psychedelic-assisted therapy. This will enable the Company to build the
infrastructure for future studies and future clinical care, while also
compiling efficacy data and providing the opportunity to evaluate the therapist
training program launched at the end of June 2021.
This program run by the Braxia
Institute, the Company's training centre focused on advancing psychiatric
clinical practice and health services of ketamine and psychedelic treatment
therapy, has already cultivated a multi-disciplinary group of 20 therapists
from diverse psychiatry and psychotherapy backgrounds to implement safe and
effective psilocybin-assisted therapy for patients with depression.
Investor ideas reminds all listeners to read our
disclaimers and disclosures on the Investorideas.com website and that this
podcast is not an endorsement to buy products or services or securities.
Investors are reminded all investment involves risk and possible loss of
investment.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The
Investorideas.com podcasts are also available on iTunes ( Apple Podcasts)
, Audible , Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio , Google
Podcasts and most audio platforms available.
Potcasts is now
a certified word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About
Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com publishes breaking stock news, third party stock research , guest posts and
original articles and podcasts in
leading stock sectors. Learn about
investing in stocks and get investor
ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable
energy, gaming and more. Investor Idea’s original branded content includes
podcasts and columns : Crypto
Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast
, Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and the AI Eye
Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact
Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
New #Stocks to Watch at Investor Ideas in Biotech (NasdaqGS: $IPSC) (NYSE: $AMAM), (NasdaqGS: $CYT) and Cannabis (CSE: $POKO.C), (CSE: $RIV.C)
New #Stocks to Watch at Investor Ideas in Biotech (NasdaqGS: $IPSC) (NYSE: $AMAM), (NasdaqGS: $CYT) and Cannabis (CSE: $POKO.C), (CSE: $RIV.C)
Also new stocks in Mining, Cleantech and Psychedelics
Point Roberts WA, Delta BC, August 27, 2021 – (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces its weekly roundup of stocks to watch in biotech, cannabis, mining, cleantech and psychedelics. Today’s stocks have been added to our lists of free stock directories in each sector.
Read this in full at https://www.investorideas.com/news/2021/main/08271Stocks.asp
The newest biotechnology companies are involved in biotech, biopharma and biomedical along with life sciences and healthcare technology.
The latest cannabis companies include both a CBD and a cannabis focused company.
The newest mining companies are both Canadian-listed, as is the latest cleantech company.
The newest psychedelics company is involved in the use of ketamine-enhanced products for psychotherapy.
New Stocks added to Biotech Stocks Directory:
FEMASYS INC (NasdaqCM:FEMY) is a biomedical company developing a suite of product candidates to transform women’s healthcare with minimally invasive, non-surgical, in-office technologies. Its two lead reproductive health product candidates include FemBloc® permanent birth control and FemaSeed™ localized directional insemination for infertility. The Company’s product for fallopian tube assessment by ultrasound FemVue®, is currently marketed in the United States. Femasys is also advancing FemCerv®, a technology platform for tissue sampling intended to be marketed alongside our other women-specific medical products in the physician’s office setting.
Codex DNA, Inc. (NasdaqGS:DNAY) is empowering scientists with the ability to address many of humanity’s greatest challenges through synthetic biology. As inventors of the industry-standard Gibson Assembly® method and the first commercial automated benchtop DNA and mRNA synthesis system, Codex DNA is enabling rapid, accurate, and reproducible writing of DNA and mRNA for numerous downstream markets. The company’s award-winning BioXp™ system consolidates, automates, and optimizes the entire synthesis, cloning, and amplification workflow. As a result, it delivers virtually error-free synthesis of DNA/RNA at scale within days and hours instead of weeks or months. Scientists around the world are using the technology in their own laboratories to accelerate the design-build-test paradigm to create novel, high-value products for precision medicine, biologics drug discovery, vaccine and therapeutic development, genome editing, and cell and gene therapy. Codex DNA is a public company based in San Diego.
Alzamend Neuro, Inc. (NasdaqCM:ALZN) is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer’s disease. Our mission is to rapidly develop and market safe and effective treatments. Our current pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic crystal-engineered combination of lithium, proline and salicylate, and AL002 – a patented therapeutic mutant-peptide sensitized cell-based therapeutic vaccine that is targeted to augment the ability of a patient’s immune system to combat Alzheimer’s disease. Both of our product candidates are licensed from the University of South Florida Research Foundation, Inc. pursuant to royalty-bearing exclusive worldwide licenses.
MOLECULAR PARTNERS AG (NasdaqGS:MOLN) is a clinical-stage biotech company developing DARPin® therapeutics, a new class of custom-built protein drugs designed to address challenges current modalities cannot. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin® therapeutics in the areas of ophthalmology, oncology and infectious disease, and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
Lyell Immunopharma, Inc. (NasdaqGS:LYEL) is a T cell reprogramming company dedicated to the mastery of T cells to cure patients with solid tumors. The Company focuses on addressing what it believes are the primary barriers that limit consistent, reliable and curative responses to adoptive T cell therapy: T cell exhaustion and lack of durable stemness, which includes proliferative capacity, ability to self-renew and ability to differentiate and eliminate solid tumors. Lyell is applying its proprietary ex vivo genetic and epigenetic reprogramming technology platforms, Gen-R and Epi-R, to address these barriers in order to develop new medicines with improved, durable, and potentially curative clinical outcomes. Lyell is based in South San Francisco, California and Seattle and Bothell, Washington.
Unicycive Therapeutics, Inc. (NasdaqCM:UNCY) is a biotechnology company developing novel treatments for kidney diseases. Unicycive's lead drug, Renazorb, is a novel phosphate binding agent being developed for the treatment of hyperphosphatemia. UNI-494 is a patent protected new chemical entity in late preclinical development for the treatment of acute kidney injury.
Cyteir Therapeutics, Inc. (NasdaqGS:CYT) is a clinical-stage oncology company that is focused on the discovery and development of next-generation synthetically lethal therapies to treat cancer. The company is using its expertise in DNA damage response biology to advance a pipeline of novel drug candidates that selectively target key cancer vulnerabilities. Cyteir’s wholly owned lead compound, CYT-0851, is a potent and selective, oral investigational drug that was designed to inhibit RAD51-mediated homologous recombination and the repair of double-strand DNA breaks.
Ambrx Biopharma Inc. (NYSE:AMAM) is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop Engineered Precision Biologics. These include next generation antibody drug conjugates (ADCs), bispecifics, targeted immuno-oncology therapies, novel cytokines to modulate the immune system, and long-acting therapeutic peptides for metabolic and cardiovascular disease. Ambrx is advancing a robust portfolio of clinical and preclinical programs designed to optimize efficacy, safety and ease of use, in multiple therapeutic areas, including its lead product candidate ARX788. In addition, the company has clinical collaborations with Bristol Myers Squibb, BeiGene, Sino Biopharma, Elanco and NovoCodex, for drug candidates generated using Ambrx technology.
Century Therapeutics, Inc. (NasdaqGS:IPSC) is harnessing the power of adult stem cells to develop curative cell therapy products for cancer that we believe will allow us to overcome the limitations of first-generation cell therapies. Our genetically engineered, iPSC-derived iNK and iT cell product candidates are designed to specifically target hematologic and solid tumor cancers. We are leveraging our expertise in cellular reprogramming, genetic engineering, and manufacturing to develop therapies with the potential to overcome many of the challenges inherent to cell therapy and provide a significant advantage over existing cell therapy technologies. We believe our commitment to developing off-the-shelf cell therapies will expand patient access and provide an unparalleled opportunity to advance the course of cancer care.
iSpecimen Inc. (NasdaqCM:ISPC) offers an online marketplace for human biospecimens, connecting life scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations.
SpotLite360 IOT Solutions, Inc. (CSE:LITE) is a supply chain and healthcare company focused on the delivery of a SaaS-based supply chain execution and sustainability platform (SpotLite 360 Software) for enterprise customers in the pharmaceutical, healthcare, and agricultural industries. By leveraging IoT technologies, blockchain, machine learning and analytics, the Spotlite360 Software is uniquely positioned to meet customer needs for supply chain execution, tracing, tracking, and sustainability. Future customers of the Spotlite360 Software will benefit by realizing improved visibility, a reduction in loss and theft, increased supply chain velocity, labor efficiency, improves asset utilization, and support of their global sustainability initiatives.
New stocks added to Cannabis Stocks Directory:
RIV Capital Inc. (CSE: RIV) is an investment and acquisition company specializing in cannabis with a portfolio of 13 companies across various segments of the cannabis value chain. We believe that bringing together people, capital, and ideas raises the potential of the entire cannabis industry. By leveraging our industry insights, in-house expertise, and thesis-driven approach to investing, we aim to provide shareholders with exposure to specialized and disruptive cannabis companies.
Poko Innovations Inc. (CSE: POKO) Formerly Brunswick Resources Inc.- is an award winning European-based company that leverages its strong portfolio of CBD brands, including financial services platform Lumipay, news and media sites, The Extract and Candid Magazine and consumer brands Poko and Canndid. These brands form a complete ecosystem that brings innovative solutions to the CBD industry-from supplying businesses with high-quality CBD-derived products and other natural health supplements to offering a reliable payment gateway service for high-risk industries and providing a CBD-focused marketplace for buyers and sellers to connect and trade. The Company has leadership teams located in Ireland, United Kingdom, Canada and the United States.
New stocks added to Mining Stocks Directory:
1111 Exploration Corp. (CSE:ELVN) is a junior exploration company, focused on creating shareholder value through acquisition, exploration and development of mineral projects.
Fokus Mining Corporation (TSXV:FKM) is a mineral resource company actively acquiring and exploring precious metal deposits located in the province of Quebec, Canada. In implementing this major undertaking within the Canadian mining industry, we are determined to unlock the secret of the Galloway gold project. The Galloway project covers an area of 2,865.54 hectares and is located just north of the Cadillac-Larder Lake deformation which extends laterally for more than 100 km. Numerous gold deposits are related to that structure and its subsidiaries. The current work focuses on a small western portion of the mineral claims where several mineral occurrences have been identified
New stocks added to Cleantech Stocks Directory:
Delta Cleantech Inc. (CSE: DELT) provides clean energy engineering services and technology in response to issues around environmental, social and corporate governance (ESG) and identity preserved waste. Delta CleanTech is a technology industry leader in CO2 Capture; Solvent & Glycol Reclamation and Hydrogen Fueling Infrastructure
New stocks added to Psychedelics Stocks Directory:
Revitalist Lifestyle and Wellness Ltd. (CSE:CALM) provides patient-focused treatments for mental health and pain disorders through the operation of psychedelic-enhanced psychotherapy clinics, which guide patients through ketamine-enhanced psychotherapy. Revivalist commenced operations in 2018 at is existing location in Knoxville Tennessee and is working on a rapid expansion in the United States. Revivalist seeks to create a global brand of psychedelic-enhanced psychotherapy clinics for ketamine-enhanced psychotherapy, psychedelic-enhanced psychotherapy, ketamine infusion therapy, vitamin infusions, and transcranial magnetic stimulation focusing on mental health and pain disorders
The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.
Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast , Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and the AI Eye Podcast.
Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining and the AI Eye.
Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com
https://www.investorideas.com/Investors/Services.asp
Learn more about advertising and guest posts
https://www.investorideas.com/Advertise/
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665 0411
Thursday 26 August 2021
Investor Ideas #Potcasts 599, #Cannabis News and #Stocks on the Move; (NASDAQ: $HUGE) (CSE: $HUGE.C), (TSX: $FAF.TO) (TSXV: $BEER.V) (TSX: $TGOD.TO) (OTC: $TGODF)
Investor Ideas #Potcasts
599, #Cannabis News and #Stocks on the Move; (NASDAQ: $HUGE) (CSE: $HUGE.C),
(TSX: $FAF.TO) (TSXV: $BEER.V) (TSX: $TGOD.TO) (OTC: $TGODF)
Delta, Kelowna, BC, August 26, 2021 (Investorideas.com Newswire)
www.Investoride, as.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast
edition of cannabis news and
stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/082621-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2021/cannabis-potcasts/08261HUGE-FAF-BEER-TGOD.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public and private company announcements.
The
Green Organic Dutchman Holdings Ltd. (TSX:
TGOD) (OTC:
TGODF), a leading producer of premium certified organically
grown cannabis, announced that it
completed its first international commercial shipment consisting of cannabis
flower and other extracts destined for the highly anticipated South African
medical cannabis market.
TGOD's cannabis flower will be the
first to be distributed legally in the country at a commercial scale. Its
products received the approval of the South African Health Products Regulatory
Authority (SAHPRA). This illustrates the value of TGOD's organic portfolio and
bolsters its position in securing international market access. TGOD continues to see demand and
opportunities for superior quality, high potency, and consistent products,
which the CleanCraft™ processes enable TGOD to deliver.
"This is an important milestone
in our strategy to export our certified organically grown medical cannabis
products to international markets. We are confident that our in-country partner
will continue to develop this nascent market and that TGOD's portfolio of
products will be well received by patients that have previously lacked access
to legal, high-quality medical cannabis " commented Sean Bovingdon, TGOD's
CEO and Interim CFO. "We are pleased to be able to complete our first
shipment mid-Q3 2021, in line with our corporate objectives. This is setting the base for our large-scale
commercialisation into the international market in 2022," added Bovingdon.
Hill
Street Beverage Company Inc. (TSXV:
BEER) announced that
its California licensee - Trinidad Consulting LLC, has started production in
preparation to launch a new THC infused line of its top-selling Cannadips
products. Powered by DehydraTECH™ fast-acting technology through a licensing
agreement with Hill Avenue Cannabis, this latest innovation follows the
extremely successful use of DehydraTECH™ technology in their national CBD
product lineup.
Based in Humboldt County,
California, Cannadips is the leading brand of smokeless nicotine and tobacco
free dips in the United States. The company currently manufactures and
distributes their popular CBD brand through exclusive licensee, Boldt Runners
Corporation, in over 5,500 stores across the US. The modern oral pouch category
is growing exponentially in the US, representing a $7 billion market category
comprised of 6.5 million smokeless tobacco users. With the launch of the new
THC line, Cannadips continues to lead innovation in the category, further
pioneering the modern dip alternative.
"We're delighted that this
latest Cannadips innovation is powered by DehydraTECH™," said Craig
Binkley, Co-CEO of Hill Street. "Our mission is to partner with brands
that are driven to deliver premium quality and category leading performance.
Cannadips aligns perfectly with these values as they constantly pursue the
highest craft quality combined with the most advanced technology to ensure that
consumers enjoy a superior experience. Cannadips has already proven that
DehydraTECH™ technology is superior through their highly successful CBD product
lineup."
Patented DehydraTECH™ technology
improves the way active pharmaceutical ingredients (APIs) enter the
bloodstream, delivering advantages such as faster onset and more predictable
cannabis experiences for consumers.
"Delivering best in category
value propositions is of utmost importance to us," said Case Mandel,
co-founder of Cannadips. "In our quest to create the ultimate smokeless,
oral cannabinoid experience for our customers, we found that DehydraTECH™ is
the perfect technology for our products and is hands-down the highest
performing technology we have tried. It preserves the valuable terpenes found
in our cannabis extracts and increases cannabinoid bioavailability, allowing
for quick absorption directly in the mouth."
The moment is right for launching
Cannadips THC, as the Cannadips brand has strong awareness with CBD/hemp
consumers which will provide a halo effect when it arrives in California
dispensaries statewide. Cannadips has developed strong partnerships that will
allow both speed to market and best in class sales and distribution. Their
manufacturing partner ArcataX Inc provides best in class manufacturing and an
exclusive distribution deal with Herbl, the largest cannabis supply chain
company in California, will be key drivers of success at retail.
"At Hill Street we have a
strong conviction to work with brands that matter. We believe in the power of
cannabis and best in class science to create product alternatives that are both
better and better for you", said Lori Senecal, Co-CEO of Hill Street.
"The Cannadips products are a shining example of this commitment. They
offer adult consumers a high quality product and a better alternative to
tobacco and nicotine with CBD and now THC infused options. We're delighted
that, with this launch, California becomes the next state where DehydraTECH™
THC will be active in the market."
The Cannadips THC line will
initially be available in two strengths. The mega-dose cans will have 500mg of
THC resulting in 25mg per pouch and the daily dose offering will contain 150mg
of THC per can, or 10mg per pouch. The new line-up is anticipated to make its
debut at the Hall of Flowers in late September and become available for
pre-order before rolling out statewide in California in October 2021.
Fire
& Flower Holdings Corp. (TSX:
FAF)
(OTCQX:
FFLWF) and its wholly-owned subsidiary Hifyre™ Inc., today
announced the proposed acquisition of all issued and
outstanding shares of PGED Corp., ("PotGuide"),
one of the world's largest cannabis websites and content platforms.
PotGuide is one of the most visited
cannabis websites in North America, as reported by industry-standard online
traffic tools. Along with the proposed acquisition of certain assets of Wikileaf
Technologies Inc. announced earlier this month, the Hifyre digital network will
become one of the world's most visited networks of cannabis websites and
content platforms.
Upon closing, the Acquisition is
expected to be immediately accretive to the Company's revenue and profitability
and will provide Hifyre with a U.S. base for technology and operations.
Following closing of the
Acquisition, Hifyre intends to leverage this significant user traffic and its
proprietary white-label dispensary e-commerce software to convert traffic into
cannabis and accessory purchases. The purchases will be fulfilled by the Fire
& Flower retail network across Canada and in California through its
agreement with Fire & Flower U.S. Holdings Inc. Hifyre anticipates creating
additional agreements with dispensary networks across Canada and the U.S. to
fulfill cannabis purchases in as many geographic locations as possible.
PotGuide and Wikileaf bring an
existing subscriber base of approximately 225,000 cannabis consumers into the
Spark Perks™ ecosystem. Subscribers will be invited to enroll in the Company's
Spark Perks™ member program, which already boasts over 300,000 subscribers. The
program allows members to unlock unique benefits and helps Hifyre build a
greater understanding of cannabis consumer preferences across North America as
part of the Hifyre IQ data program.
"As Fire & Flower has grown
over the past few years, we have successfully proven the value of our Hifyre
data analytics retail platform and it is a great accomplishment to see the
rapid success of our expanding digital strategy with the acquisition of
PotGuide," shared Trevor Fencott, Chief Executive Officer of Fire &
Flower. "Now that we are strategically acquiring two of the most visited
cannabis online websites, PotGuide and Wikileaf, we have established Fire &
Flower and Hifyre as leading global players in digital cannabis traffic and
believe we can offer even greater value to these high-demand properties."
"PotGuide is excited to join
the Fire & Flower and Hifyre network of properties and we look forward to
continuing to build one of the leading North American cannabis technology
companies," shared Jeremy Bamford, Chief Executive Officer of PGED Corp.
"The ability to leverage the significant web traffic of PotGuide.com with
Hifyre's cannabis e-commerce technology will enable us to offer an increased
value proposition to our users and enhance the growth strategy of our
business."
FSD Pharma Inc. (NASDAQ:
HUGE) (CSE:
HUGE), a life sciences holding company dedicated to
building a portfolio of assets and biotech solutions in legal psychedelics and
medical cannabis, announced that it
has entered a definitive agreement to acquire 100% of the issued and outstanding
shares Lucid Psycheceuticals Inc., a Canadian-based specialty psychedelic
pharmaceutical company focused on the development of therapies to treat
critical neurodegenerative diseases, for approximately US$9 million (CAD$11.3
million) in FSD Pharma stock (the "Transaction"), as further
described below.
"The
acquisition of a distinctive company like Lucid illustrates FSD Pharma’s vision
to build a portfolio of biotechnology assets on a new frontier of medicine that
hold the potential to treat mental health disorders and neurodegenerative
diseases in a new way," said Anthony Durkacz, Interim CEO of FSD Pharma.
"Lucid has successfully developed a strong pipeline of novel therapeutic
compounds — supported by IP in order to advance to future clinical trials — and
we are confident that the experience the Lucid leadership team brings will
allow us to immediately start the process towards clinical trials to further
advance these promising therapies. This is an exciting venture for FSD Pharma
that we believe represents a paradigm shift in the development and outlook of
our company."
Founded
in 2020, Lucid is developing novel molecules and combinations with the goal of
addressing Total Brain Health and targeting some of the most challenging
neurodegenerative diseases, such as Multiple sclerosis, and other Brain
conditions. Lucid has exclusive worldwide licensing rights from the University
Health Network, North America’s largest health research organization, to a
patent-protected family of new chemical entities (NCEs), on which Lucid’s
development platform is based and from which its lead neurodegenerative
disorders therapeutic candidate, Lucid-21-302, has been derived. In addition,
Lucid’s pipeline includes Lucid-201, a psychedelic drug candidate targeting mental
health disorders, and it is also investigating certain cannabinoids.
In
addition, upon closing of the transaction Lucid’s co-founder and CEO, Dr.
Lakshmi Kotra will be transitioning to the FSD Pharma team with Prof. Kotra
taking on the role of leading the development of FSD Pharma’s drug development
pipeline in Psychedelics and Medical Cannabis. Dr. Kotra is a Professor of
Medicinal Chemistry at the University of Toronto, and senior scientist at
Krembil Brain Institute at the University Health Network.
Prof.
Lakshmi Kotra, co-founder and CEO of Lucid, commented, "We started with a
vision to accelerate therapies for Total Brain Health. Since inception, we have
made significant progress and built a strong scientific and execution team. We
are excited to enter a new phase of growth with FSD Pharma. I am personally
delighted with FSD Pharma leadership’s shared commitment to bring forward
advanced therapeutics addressing challenging health issues. We believe our
combined resources and experienced teams will position us to enter clinical
development programs to deliver highly effective therapeutic products in
neurodegenerative disorders and mental health areas."
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and that this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment.
Learn
more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com podcasts
visit: https://www.investorideas.com/Audio/.
The Investorideas.com podcasts are also
available on iTunes ( Apple Podcasts) ,
Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio , Google Podcasts and most audio platforms
available.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big
Investing Ideas
Investorideas.com
publishes breaking stock news, third
party stock research , guest posts and original
articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and
IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor
Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play
sports and stock news , Investor Ideas Potcasts
Cannabis News and Stocks on the Move podcast , Cleantech and Climate
Change , Exploring Mining , Betting on Gaming Stocks
Podcast and the AI Eye
Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and
equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investing involves risk and possible losses. This
site is currently compensated for news publication and distribution, social
media and marketing, content creation and more. Disclosure is posted for each
compensated news release, content published /created if required but otherwise
the news was not compensated for and was published for the sole interest of our
readers and followers. Contact
management and IR of each company directly regarding specific questions. More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile
App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665 0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
Cannabis Stocks in Play - Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) Joins TSX most active traders listEED) (NASDAQ: CGC) Joins TSX most active traders list">
Cannabis Stocks in Play - Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) Joins TSX most active traders listEED) (NASDAQ: CGC) Joins TSX...
-
Investorideas.com - Cannabis Stock News: TransCanna (CSE: TCAN) Product Ranks in Leafly's Top Cannabis Strains List
-
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ...